Phase I study of ABSK021 in patients with advanced solid tumors
Latest Information Update: 31 Dec 2020
At a glance
- Drugs Pimicotinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Abbisko Therapeutics
- 31 Dec 2020 New trial record